---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42850916.md"
description: "$Aehr Test(AEHR.US) surged 28% today, with earnings again beating expectations—Q4 FY revenue of $18.8M, up 34% YoY, and EPS of $0.11 directly smashing previous expectations that were close to breakeven. More importantly, it provided FY27 revenue guidance of $130M to $150M, corresponding to 160% to 200% growth.Demand for wafer-level testing related to AI and electric vehicles is driving orders, with single-quarter bookings of $60.7M and a backlog exceeding $100M. The elasticity of small-cap semiconductor test equipment, when combined with better-than-expected guidance, creates this kind of explosive power, leading to a re-rating of valuations."
datetime: "2026-07-22T10:07:12.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42850916.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42850916.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42850916.md)
author: "[好事连连](https://longbridge.com/en/profiles/27514675.md)"
---

# $Aehr Test(AEHR.US) surged 28% today, with earning…


### Related Stocks

- [AEHR.US](https://longbridge.com/en/quote/AEHR.US.md)